Canada Pension Plan Investment Board’s Dutch Bros BROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.7M Sell
664,039
-87,963
-12% -$5.05M 0.03% 397
2026
Q1
$38.1M Buy
752,002
+455,724
+154% +$24.9M 0.02% 393
2025
Q4
$18.1M Buy
296,278
+114,700
+63% +$6.52M 0.01% 527
2025
Q3
$9.5M Buy
181,578
+52,978
+41% +$3.35M 0.01% 652
2025
Q2
$8.79M Buy
128,600
+90,300
+236% +$5.89M 0.01% 618
2025
Q1
$2.36M Sell
38,300
-135,400
-78% -$8.92M ﹤0.01% 788
2024
Q4
$9.1M Sell
173,700
-223,500
-56% -$9.86M 0.01% 610
2024
Q3
$12.7M Buy
397,200
+205,000
+107% +$7.23M 0.01% 526
2024
Q2
$7.96M Buy
192,200
+161,800
+532% +$5.56M 0.01% 623
2024
Q1
$1M Buy
+30,400
New +$897K ﹤0.01% 1032
2023
Q1
– Sell
-2,000
Closed -$56.4K – 1077
2022
Q4
$56.4K Sell
2,000
-1,600
-44% -$52.9K ﹤0.01% 1067
2022
Q3
$112K Buy
3,600
+2,000
+125% +$75.3K ﹤0.01% 1074
2022
Q2
$51K Buy
+1,600
New +$65.6K ﹤0.01% 1176

Other funds holding BROS

Canada Pension Plan Investment Board's BROS Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Dutch Bros (BROS) stake by 12% in Q2 2026, selling an estimated $5.05M and leaving 664,039 shares worth $47.7M. The position accounts for 0.03% of the portfolio, ranked #397.

Canada Pension Plan Investment Board first reported a position in BROS in Q2 2022 and has held it in 13 quarters since. 559 funds tracked by Wall St. Rank hold BROS as of Q2 2026.

  • Canada Pension Plan Investment Board held 664,039 shares of Dutch Bros worth $47.7M as of Q2 2026.
  • Canada Pension Plan Investment Board sold 87,963 Dutch Bros shares in Q2 2026, an estimated $5.05M.
  • Dutch Bros made up 0.03% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #397 holding.
  • Canada Pension Plan Investment Board first reported a position in Dutch Bros in Q2 2022 and has held it in 13 quarters since.
  • 559 funds tracked by Wall St. Rank held Dutch Bros as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.